A detailed history of Virtu Financial LLC transactions in Aquestive Therapeutics, Inc. stock. As of the latest transaction made, Virtu Financial LLC holds 22,986 shares of AQST stock, worth $108,264. This represents 0.01% of its overall portfolio holdings.

Number of Shares
22,986
Previous 37,901 39.35%
Holding current value
$108,264
Previous $99,000 15.15%
% of portfolio
0.01%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 20, 2024

SELL
$2.4 - $5.09 $35,796 - $75,917
-14,915 Reduced 39.35%
22,986 $114,000
Q2 2024

Aug 09, 2024

SELL
$2.31 - $4.5 $149,999 - $292,207
-64,935 Reduced 63.14%
37,901 $99,000
Q1 2024

May 20, 2024

BUY
$2.01 - $6.09 $142,038 - $430,355
70,666 Added 219.66%
102,836 $438,000
Q4 2023

Feb 26, 2024

BUY
$1.29 - $2.47 $41,499 - $79,459
32,170 New
32,170 $65,000
Q1 2023

May 01, 2023

BUY
$0.72 - $1.15 $9,276 - $14,816
12,884 New
12,884 $15,000
Q2 2022

Aug 09, 2022

BUY
$0.64 - $2.57 $61,243 - $245,931
95,693 Added 893.08%
106,408 $68,000
Q1 2022

May 17, 2022

SELL
$2.28 - $4.26 $156,004 - $291,481
-68,423 Reduced 86.46%
10,715 $28,000
Q4 2021

Feb 17, 2022

BUY
$3.69 - $6.37 $292,019 - $504,109
79,138 New
79,138 $308,000
Q3 2021

Nov 12, 2021

SELL
$3.25 - $4.66 $60,193 - $86,307
-18,521 Closed
0 $0
Q2 2021

Sep 17, 2021

BUY
$3.29 - $5.21 $60,934 - $96,494
18,521 New
18,521 $74,000
Q1 2021

May 19, 2021

SELL
$4.17 - $6.73 $246,238 - $397,406
-59,050 Closed
0 $0
Q4 2020

Feb 24, 2021

SELL
$4.65 - $7.79 $270,425 - $453,035
-58,156 Reduced 49.62%
59,050 $316,000
Q3 2020

Dec 11, 2020

BUY
$4.12 - $9.09 $437,844 - $966,021
106,273 Added 972.04%
117,206 $569,000
Q2 2020

Aug 07, 2020

BUY
$1.84 - $6.44 $20,116 - $70,408
10,933 New
10,933 $53,000

Others Institutions Holding AQST

About Aquestive Therapeutics, Inc.


  • Ticker AQST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 53,350,700
  • Market Cap $251M
  • Description
  • Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...
More about AQST
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.